Inventor · disambiguated record
Douglas James Riexinger
Also filed as: RIEXINGER DOUGLAS · RIEXINGER DOUGLAS J · RIEXINGER DOUGLAS JAMES
9 granted patents·5 pending applications·113 citations·filing 1994–2016
88Inventor score
Top patents by PatentIndex Score
14 records- 0191US7417028B2Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·20 cites·22 claims
- 0289US9605024B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 28, 2017·4 cites·16 claims
- 0386US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0481US9303065B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 5, 2016·2 cites·4 claims
- 0581US8927688B2PAR4 agonist peptidesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 6, 2015·2 cites·13 claims
- 0677US7960349B2N-terminally modified GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 14, 2011·2 cites·18 claims
- 0777US6111065APeptide inhibitors of inflammation mediated by selectinsCENTOCOR INC·Filed 1994·Granted Aug 29, 2000·58 cites·12 claims
- 0875US7314726B2Beta secretase exosite binding peptides and methods for identifying beta secretase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 1, 2008·6 cites·3 claims
- 0958US5464935APeptide inhibitors of selectin bindingCENTOCOR INC·Filed 1995·Granted Nov 7, 1995·14 cites·1 claims
- 1056US2008242593A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1151US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1245US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1342US2007149763A1Beta secretase exosite binding peptides and methods for identifying beta secretase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1441US2007021346A1N-terminally modified GLP-1 receptor modulatorsEWING WILLIAM R·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →